Tejnaksh Healthcare (BSE 539428)₹13.00+2.44%Healthcare Service Provider
In the Jun 2026 quarter (consolidated), Tejnaksh Healthcare reported sales of ₹2.66 Cr, up 0.4% from Jun 2025, and net profit of ₹0.25 Cr, up 25.0% year on year. For the year to Mar 2026, sales were ₹10.82 Cr and net profit ₹1.17 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.10 | 3.15 | 2.93 | 3.13 | 3.38 | 3.20 | 3.22 | 2.65 | 2.99 | 2.63 | 2.56 | 2.66 |
| Expenses | 1.95 | 2.06 | 2.00 | 2.03 | 2.20 | 2.04 | 2.49 | 2.03 | 2.20 | 1.92 | 1.83 | 1.95 |
| Operating Profit | 1.12 | 1.06 | 0.90 | 1.07 | 1.15 | 1.13 | 0.70 | 0.59 | 0.76 | 0.68 | 0.70 | 0.68 |
| OPM % | 36.7% | 34.1% | 31.2% | 34.7% | 34.4% | 35.8% | 22.2% | 22.8% | 25.9% | 26.4% | 27.9% | 26.1% |
| Other Income | 0.07 | 0.06 | 0.06 | 0.06 | 0.08 | 0.16 | 0.06 | 0.08 | 0.08 | 0.06 | 0.13 | 0.09 |
| Interest | 0.15 | 0.18 | 0.13 | 0.11 | 0.10 | 0.13 | 0.00 | 0.04 | 0.02 | 0.03 | −0.02 | 0.00 |
| Depreciation | 0.22 | 0.22 | 0.22 | 0.22 | 0.30 | 0.19 | 0.16 | 0.35 | 0.34 | 0.35 | 0.35 | 0.34 |
| Profit before tax | 0.83 | 0.73 | 0.62 | 0.81 | 0.84 | 0.98 | 0.61 | 0.29 | 0.49 | 0.37 | 0.53 | 0.44 |
| Tax % | 26.8% | 24.9% | 26.2% | 24.9% | 21.6% | 42.2% | 28.3% | 28.5% | 33.3% | 19.4% | 32.6% | 37.1% |
| Net Profit | 0.60 | 0.53 | 0.45 | 0.59 | 0.64 | 0.55 | 0.41 | 0.20 | 0.32 | 0.27 | 0.34 | 0.25 |
| EPS (Rs) | 0.30 | 0.28 | 0.26 | 0.31 | 0.32 | 0.31 | 0.26 | 0.13 | 0.16 | 0.16 | 0.19 | 0.14 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.76 | 7.29 | 14.16 | 19.79 | 17.16 | 11.99 | 12.72 | 11.75 | 12.20 | 12.92 | 10.82 | 10.84 |
| Expenses | 2.44 | 4.07 | 8.77 | 15.53 | 13.04 | 8.21 | 7.86 | 8.01 | 8.53 | 8.77 | 7.98 | 7.90 |
| Operating Profit | 2.29 | 3.19 | 5.32 | 4.17 | 4.02 | 3.71 | 4.78 | 3.69 | 3.62 | 4.08 | 2.77 | 2.82 |
| OPM % | 48.5% | 44.0% | 37.8% | 21.2% | 23.6% | 31.2% | 37.9% | 31.6% | 29.9% | 31.8% | 25.8% | 26.0% |
| Other Income | 0.02 | 0.18 | 0.38 | 1.54 | 0.33 | 0.12 | 0.10 | 0.30 | 0.30 | 0.39 | 0.38 | 0.36 |
| Interest | 0.00 | 0.19 | 0.97 | 0.77 | 0.75 | 0.49 | 0.47 | 0.61 | 0.65 | 0.39 | 0.09 | 0.03 |
| Depreciation | 0.20 | 0.34 | 0.46 | 0.58 | 0.64 | 0.67 | 0.66 | 0.86 | 0.90 | 0.90 | 1.42 | 1.38 |
| Profit before tax | 2.13 | 2.85 | 4.29 | 4.37 | 2.98 | 2.68 | 3.77 | 2.53 | 2.38 | 3.20 | 1.65 | 1.83 |
| Tax % | 37.7% | 32.7% | 25.6% | 28.1% | 27.5% | 22.4% | 25.2% | 28.5% | 25.7% | 30.0% | 28.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.04 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 1.31 | 1.81 | 3.17 | 3.13 | 2.14 | 2.06 | 2.80 | 1.78 | 1.76 | 2.22 | 1.17 | 1.18 |
| EPS (Rs) | 0.66 | 0.91 | 1.43 | 1.50 | 1.04 | 1.02 | 1.35 | 0.84 | 0.89 | 1.16 | 0.62 | 0.65 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.10 | 2.21 | 2.21 | 10.19 | 10.16 | 10.18 | 10.17 | 10.18 | 10.17 | 10.17 | 10.17 |
| Reserves | 5.14 | 5.86 | 7.95 | 3.01 | 5.10 | 7.18 | 9.92 | 11.64 | 13.44 | 15.78 | 17.03 |
| Borrowings | 0.00 | 6.39 | 7.65 | 6.35 | 7.20 | 4.90 | 7.00 | 6.43 | 4.81 | 1.05 | 0.25 |
| Other Liabilities | 0.61 | 1.08 | 1.99 | 2.79 | 2.48 | 2.37 | 2.57 | 3.06 | 3.00 | 3.37 | 2.66 |
| Total Liabilities | 6.85 | 15.54 | 19.80 | 22.34 | 24.94 | 24.63 | 29.66 | 31.31 | 31.42 | 30.37 | 30.11 |
| Fixed Assets | 3.35 | 13.63 | 15.36 | 17.02 | 17.40 | 15.08 | 15.41 | 23.48 | 23.28 | 21.22 | 21.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.40 | 0.66 | 0.80 | 8.92 | 0.96 | 1.08 | 1.34 | 0.00 |
| Investments | 2.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.92 | 1.91 | 4.44 | 4.92 | 6.88 | 8.75 | 5.33 | 6.87 | 7.06 | 7.81 | 8.13 |
| Inventories | 0.19 | 0.31 | 0.73 | 0.84 | 0.65 | 0.71 | 0.73 | 0.68 | 0.82 | 0.80 | 0.84 |
| Trade receivables | 0.00 | 0.00 | −0.04 | 0.20 | 0.54 | 0.48 | 0.58 | 1.59 | 0.53 | 1.86 | 2.19 |
| Cash & equivalents | 0.48 | 1.14 | 1.73 | 1.23 | 1.28 | 1.22 | 2.99 | 3.12 | 4.24 | 1.78 | 2.02 |
| Total Assets | 6.85 | 15.54 | 19.80 | 22.34 | 24.94 | 24.63 | 29.66 | 31.31 | 31.42 | 30.37 | 30.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 3.68 | 2.26 | 4.50 | 3.16 | 1.17 | 1.19 | 9.23 | 2.13 | 4.02 | 0.39 | 1.73 |
| Cash from investing activity | −3.25 | −8.02 | −3.23 | −1.54 | −1.20 | 1.55 | −10.58 | −1.39 | −1.00 | 3.51 | −0.27 |
| Cash from financing activity | −0.12 | 6.41 | −0.65 | −2.08 | 0.09 | −2.79 | 1.61 | −1.19 | −2.26 | −3.86 | −1.23 |
| Net cash flow | 0.30 | 0.66 | 0.60 | −0.51 | 0.06 | −0.07 | 0.25 | −0.49 | 0.74 | 0.04 | 0.20 |
| Capex | 0.67 | 10.57 | 1.48 | 1.56 | 1.30 | 0.56 | 9.13 | 0.93 | 0.82 | 0.50 | 0.50 |
| Free cash flow | 3.00 | −8.38 | 3.01 | 1.59 | −0.16 | 2.69 | 0.10 | 1.20 | 3.19 | 1.27 | 1.24 |
| CFO / OP % | 160.0% | 69.9% | 104.0% | 94.0% | 40.9% | 13.0% | 186.9% | 45.9% | 120.0% | 20.9% | 91.9% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | −1 | 4 | 11 | 14 | 16 | 49 | 16 | 52 | 74 |
| Inventory days | 98 | 130 | 221 | 255 | 180 | 284 | 185 | 173 | 233 | 224 | 297 |
| Days payable | 114 | 226 | 227 | 184 | 152 | 191 | 100 | 140 | 63 | 85 | 86 |
| Cash conversion cycle | −15 | −95 | −6 | 75 | 40 | 109 | 102 | 84 | 186 | 192 | 286 |
| Working capital days | −2 | 5 | −43 | 19 | 75 | 9 | 7 | 44 | 3 | 81 | 89 |
| ROCE % | — | 29.2% | 32.2% | 27.1% | 17.4% | 13.9% | 17.0% | 11.1% | 10.4% | 12.7% | 6.3% |
For the Jun 2026 quarter, Tejnaksh Healthcare reported sales of ₹2.66 Cr, up 0.4% year on year and net profit of ₹0.25 Cr, up 25.0% year on year. The operating margin was 26.1%.
Tejnaksh Healthcare's sales for the year to Mar 2026 were ₹10.82 Cr; over the last twelve months they were ₹10.84 Cr.
Net profit for the year to Mar 2026 was ₹1.17 Cr, and ₹1.18 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.65.
Tejnaksh Healthcare reported borrowings of ₹0.25 Cr at Mar 2026, against cash and equivalents of ₹2.02 Cr.
Cash from operations was ₹1.73 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.24 Cr.